Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    553 - Can you use "New" in APS for a product that has been on the market but has had their indication revised/expanded?

    Claims & Support/References for Claims
    1
    1
    73
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      Terms related to or suggesting “new” should be restricted to one year post marketing (Code section 11). If there is a change to the terms or market authorization that changes the products scope, it can be used for one year post the change, however, the copy should be clearly limited to the feature that is new (i.e. “new data”, “new indication in population X”). As an example, addition of an indication in pediatrics, should be clearly limited to this population, not a broad and open statement of “new”. Similarly, a revision to the indication which creates a greater restriction on the use of the product, should not be positioned as a “new” indication, but as a new restriction on use.

      1 Reply Last reply Reply Quote 0
      • First post
        Last post